University of Ioannina
Εκτίμηση κλειστών κρανιοεγκεφαλικών κακώσεων με ανοσοϊστοχημικούς δείκτες σε νεκροτομικό υλικό
Abstract
dc:descriptionIn recent years, the use of the immunohistochemical method with the contribution of modern immunohistochemical techniques for the study of histopathological lesions in traumatic axial injury due to closed craniocerebral injury has become more frequent. More specifically: antibodies against astroglial S-100B protein, glial fibrillar acidic protein (GFAP), chromogranin A, basic fibroblast growth factor (bFGF, basic vascular endothelium) NSE, neuron-specific enolase), β-amyloid precursor protein (β-APP, amyloid precursor protein), etc., appear to have prognostic value in diffuse axial damage. Orexines (Orexines A and B) or hypocretins are neuropeptides that have a variety of physiological effects, including the regulation of the sleep-wake cycle, appetite, and other neuroendocrine functions. Recent in vivo studies suggest that the orexin system may be involved in traumatic brain injury and their finding appears to be related to the patient's prognosis. The aim of the present study was to investigate the expression of orexin in brain sections and the possible association with S-100B protein, glial fibrous acid protein (GFAP), and β-amyloid precursor protein, β-amyloid. amyloid precursor protein) by the application of modern immunohistochemical techniques. Road accident is the most common cause of closed craniocerebral injury. The majority of victims are men under the age of 45.Diffuse axial injury or traumatic axial injury occurs after mild, moderate, and severe craniocerebral injury, usually in road accidents and injuries from falling from a significant height. The use of β-amyloid precursor protein (β-APP), by the method of immunohistochemistry, to assess the extent of axial damage in a variety of pathological processes proved to be a useful tool in forensic practice for the assessment of traumatic axial damage. Diffuse traumatic axial injury in humans has been demonstrated by the immunoreactivity of β-APP in patients who survived at least 2 h after head injury. Immunohistochemical staining of β-APP is a useful diagnostic indicator of diffuse axial damage in the daily practice of forensic medicine, provided that sufficient and appropriate samples are taken from specific areas, making it possible to diagnose in a large percentage of cases. This method is sensitive, reliable, fast and low cost for detecting axial damage in traumatic brain injury. Immune response to β-APP in the absence of visible macroscopic traumatic brain injury suggests that even mild head injuries can lead to axial damage and could go undiagnosed during necropsy and histopathology. In the present study it was observed, using the immunohistochemical method, the expression of ORX-A neurons in the hypothalamus was significantly reduced in the first 24 hours in cases of diffuse axial damage after closed craniocerebral injury. In addition, there is a statistically significant difference between the immunoprecipitation of ORX-A and the immunoprecipitation of β-APP, in the sense that the more diffuse and intense the expression of β-APP, the lower the expression of ORX-A in orexin neurons. In our study we observed astrocyte neoplasm in the first 6 hours after craniocerebral injury with a significant increase in 24 to 48 hours, using GFAP. Morover, the immunoreactivity of S100B protein was observed after 8 hours from the craniocerebral injury. Therefore, the Histology should be used as a tool in daily practice by Forensic Pathologists and Neuropathologists in cases of craniocerebral injuries and where there is evidence of diffuse axial damage, using the immunohistochemical method the diagnosis is confirmed.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kousi, Chrysavgi
- Κούση, Χρυσαυγή
Subjects
dc:subject × 20- Κλειστές κρανιοεγκεφαλικές κακώσεις
- Διάχυτη αξονική βλάβη
- Σύγχρονες ανοσοϊστοχημικές μέθοδοι
- Ορεξίνη α και β
- Close brain injuries
- Diffuse Brain Injuries
- Modern Immunohistochemical Techniques
- Orexin a and b
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Νευροεπιστήμες
- Παθολογοανατομία
- Κλινική Ιατρική
- Νευροαπεικόνιση
- Basic Medicine
- Medical and Health Sciences
- Neurosciences
- Pathology
- Clinical Medicine
- Neuroimaging
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/51571